We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer

By LabMedica International staff writers
Posted on 29 Oct 2020

Image: World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer (Photo courtesy of Bosch Healthcare)

Image: World’s Fastest PCR-Based SARS-CoV-2 Test Now Available on Randox-Bosch Vivalytic POC Analyzer (Photo courtesy of Bosch Healthcare)

A rapid new coronavirus test, which provides results for COVID-19 in just 39 minutes, is now available on the Vivalytic, a point of care platform brought to market by Randox Laboratories (Crumlin, UK) and Bosch Healthcare (Waiblingen, Germany).

The test for detection of the SARS-CoV-2 pathogen, is currently the fastest PCR test (the gold standard of test methods) worldwide, and is predestined for decentralized use in mobile test centers at service stations or in airports, so that people who take the test can obtain a reliable result while at the testing site. The advantages of the rapid SARS-CoV-2 test on Vivalytic lie not only in speedy analysis, but also in ease of use. A sample is taken from the nose or throat using a swab, and placed in the test cartridge. Then the cartridge, which contains all the reagents required for the test, is inserted into the Vivalytic device for automated analysis. Available now in Europe, the CE-approved test, which has a sensitivity of 98% and a specificity of 100%, helps avoid time in quarantine, relieve laboratories, and make travel and work safer again.

“Rapid and accurate testing plays a crucial role in identifying cases of Covid-19 – to contain any outbreaks and limit the spread of the virus,” said Dr. Heather McMillan, Molecular R&D Manager at Randox Biosciences. “This new rapid test will be a game-changer in the coronavirus testing landscape by allowing patients to receive their results at the point of care faster than ever before.”

“With our different coronavirus tests and variable analysis strategies, we open up a range of testing scenarios with a Vivalytic device - from screening all the way to supporting differential diagnosis for similar symptoms,” added Marc Meier, president of Bosch Healthcare Solutions GmbH.

Visit expo >

Gold Member

SARS-CoV-2 Reactive & Non-Reactive Controls

Qnostics SARS-CoV-2 Typing

Serological Pipet Controller
PIPETBOY GENIUS

New

Celiac Disease Test

Anti-Gliadin IgG ELISA

New

Gold Member

Quality Control Material

iPLEX Pro Exome QC Panel

DIASOURCE (A Biovendor Company)

Latest COVID-19 News

Channels

Clinical Chemistry

view channel

Image: The new research involved using digital PCR as a reference method to standardize test results between laboratories (Photo courtesy of Adobe Stock)

New Reference Measurement Procedure Standardizes Nucleic Acid Amplification Test Results

Nucleic acid amplification tests (NAATs) play a key role in diagnosing a wide range of infectious diseases. These tests are generally known for their high sensitivity and specificity, and they can be developed... Read more

Image: A pen-like tool collects molecules from the skin that can be screened for opioids (Photo courtesy of William Clarke/Johns Hopkins)

Pen-Like Tool Quickly and Non-Invasively Detects Opioids from Skin

Opioid drugs such as fentanyl, morphine, and oxycodone are the primary substances associated with overdose cases in the United States. Standard drug screening procedures typically involve collecting blood,... Read more

Image: The spectroscopy and AI-powered urine-based test detects 10 cancers (Photo courtesy of 123RF)

Simple Urine Test Could Detect Multiple Cancers at Early Stage

When disease is present, the human body releases tiny molecules known as volatile organic compounds (VOCs). Now, a spectroscopy and artificial intelligence (AI)-powered urine-based test uses scent-based... Read more

Image: Ear wax could be a possible screening medium for Parkinson’s disease (Photo courtesy of 123RF)

Earwax Test Accurately Detects Parkinson’s by Identifying Odor Molecules

Current tests for Parkinson’s disease (PD) rely heavily on clinical scales and neuroimaging, which are often subjective, expensive, and ill-suited for routine screening. Since most treatments only slow... Read more

Molecular Diagnostics

view channel

Genetic Test Could Predict Poor Outcomes in Lung Transplant Patients

Organ transplantation has dramatically transformed the management of patients suffering from organ failure. Yet, the immune system of the recipient often perceives the transplanted organ as a foreign entity,... Read more

Image: The Avantect Pancreatic Cancer Test enables early detection of pancreatic cancer in high-risk patients (Photo courtesy of ClearNote Health)

Breakthrough Blood Test Enables Early Pancreatic Cancer Detection

Pancreatic cancer ranks as the fourth-leading cause of cancer-related deaths in the United States. At present, there are no molecular tools available for the early detection of this disease.... Read more

Image: A new study has showcased the significant impact of genomic testing in the NICU (Photo courtesy of 123RF)

Genomic Testing in NICU Reduces Missed Diagnoses

There remains a significant shortfall in the current system of neonatal care—many critically ill newborns, especially those from underserved backgrounds, are not being offered genetic testing, resulting... Read more

Image: A genetics study has led to largescale diabetes clinical trial launch in Chinese hospitals (Photo courtesy of University of Adobe Stock)

New Genetic Test Improves Diabetes Prediction and Classification

Diabetes disrupts the body’s ability to control blood sugar levels. Type 1 diabetes arises when the immune system mistakenly destroys the pancreas’ insulin-producing beta cells, requiring patients to take... Read more

Hematology

view channel

Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Image: The FINDER multifunctional testing platform can run multiple types of tests and deliver rapid results for near-patient use (Photo courtesy of Baebies)

First Point-of-Care Heparin Monitoring Test Provides Results in Under 15 Minutes

Heparin dosing requires careful management to avoid both bleeding and clotting complications. In high-risk situations like extracorporeal membrane oxygenation (ECMO), mortality rates can reach about 50%,... Read more

Image: The 3-parameter CCRS model was devised specifically for patients diagnosed with clonal cytopenia (Photo courtesy of 123RF)

New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder

Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more

Image: The technology has the unique ability to detect challenging RhD variants that are typically excluded by other commercial tests (Photo courtesy of BillionToOne)

Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy

In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more

Immunology

view channel

Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Image: Schematic overview of the deep learning-based circulating exosome analysis for lung cancer detection (Photo courtesy of Chuan Xu, Cheng Jiang)

Liquid Biopsy Approach to Transform Diagnosis, Monitoring and Treatment of Lung Cancer

Lung cancer continues to be a major contributor to cancer-related deaths globally, with its biological complexity and diverse regulatory processes making diagnosis and treatment particularly difficult.... Read more

Image: The new tool shines a light on elusive genomic patterns (Photo courtesy of Adobe Stock)

Computational Tool Exposes Hidden Cancer DNA Changes Influencing Treatment Resistance

Structural changes in tumor DNA are among the most damaging genetic alterations in cancer, yet they often go undetected, particularly when tissue samples are degraded or of low quality. These hidden genomic... Read more

Image: NGS can detect one tumor cell among a million healthy cells from a simple blood sample (Photo courtesy of Shutterstock)

New Tool Detects Breast Cancer Relapses Five Years in Advance

Relapse detection in patients with solid tumors—particularly hormone receptor-positive (HR+) breast cancer—remains a major clinical challenge, as many patients initially respond well to treatment but later... Read more

Microbiology

view channel

Image: The new handheld TB testing device significantly improves disease detection in HIV patients (Photo courtesy of Vincent Postle/Tulane University)

Credit Card-Sized Test Boosts TB Detection in HIV Hotspots

Current tuberculosis (TB) tests face major limitations when it comes to accurately diagnosing the infection in individuals living with HIV. HIV, a frequent co-infection with TB, complicates detection by... Read more

Fecal Metabolite Profiling Predicts Mortality in Critically Ill Patients

Critically ill patients in medical intensive care units (MICUs) often suffer from conditions such as acute respiratory distress syndrome (ARDS) or sepsis, which are linked to reduced diversity of gut microbiota... Read more

Image: Lodestar UTI tests for six pathogen that, together, cause about 85% of all UTI infections (Photo courtesy of Llusern Scientific)

Portable Molecular POC System Rules Out UTIs in Just 35 Minutes

Urinary tract infections (UTIs) represent a massive burden on patients and healthcare systems. There are over 400 million UTI cases globally each year, of which around 90% are in women. Fast and accurate... Read more

POC Lateral Flow Test Detects Deadly Fungal Infection Faster Than Existing Techniques

Diagnosing mucormycosis—an aggressive and often deadly fungal infection—remains a major challenge due to the disease’s rapid progression and the lack of fast, accurate diagnostic tools. The problem became... Read more

Pathology

view channel

AI-Driven Preliminary Testing for Pancreatic Cancer Enhances Prognosis

Pancreatic cancer poses a major global health threat due to its high mortality rate, with 467,409 deaths and 510,992 new cases reported worldwide in 2022. Often referred to as the "king" of all cancers,... Read more

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more

Image: The Aiforia Breast Cancer Grading AI solution is CE-IVD marked (Photo courtesy of Aiforia Technologies)

Clinical AI Solution for Automatic Breast Cancer Grading Improves Diagnostic Accuracy

Labs that use traditional image analysis methods often suffer from bottlenecks and delays. By digitizing their pathology practices, labs can streamline their work, allowing them to take on larger caseloads... Read more

Image: Saliva still remains underutilized in clinical practice (Photo courtesy of UPV/EHU)

Saliva-Based Testing to Enable Early Detection of Cancer, Heart Disease or Parkinson’s

Saliva is one of the most accessible biological fluids, yet it remains underutilized in clinical practice. While saliva samples are used to perform genetic tests to determine, for example, paternity, the... Read more

Technology

view channel

Image: The actual chip of human leukemia bone marrow where chambers and channels were filled with food dyes (Photo courtesy of Weiqiang Chen/NYU Tandon Applied Micro-Bioengineering Laboratory)

New Miniature Device to Transform Testing of Blood Cancer Treatments

Chimeric antigen receptor (CAR) T cell therapy has emerged as a groundbreaking treatment for blood cancers like leukemia, offering hope to patients when other treatments fail. However, despite its promise,... Read more

Image: Synthesis, optical, and electron microscopy characterization of magneto-plasmonic cryosorets (Photo courtesy of APL Mater. 13, 041103 (2025); doi.org/10.1063/5.0251312)

Biosensing Advancement to Enable Early Detection of Disease Biomarkers at POC

Traditional medical diagnostics often require clinical samples to be sent off-site, leading to time-consuming and costly processes. Point-of-care diagnostics offer a more efficient alternative, allowing... Read more

New POC Biosensing Technology Improves Detection of Molecular Biomarkers

Traditional diagnostic procedures in medicine typically involve sending a patient’s blood or tissue samples to clinical laboratories, where trained scientists perform testing and data interpretation.... Read more

Enhanced Lab Data Management and AI Critical to Labs of the Future, Finds Survey

Data plays a key role in the transformation of today’s digital laboratories, acting both as a key challenge and a catalyst for innovation, as revealed by a survey of over 150 scientists.... Read more

Industry

view channel

Image: The AMP’s best practice recommendations are for clinical laboratories developing and performing HRD testing (Photo courtesy of 123RF)

AMP Releases Best Practice Recommendations to Guide Clinical Laboratories Offering HRD Testing

Homologous recombination deficiency (HRD) testing identifies tumors that are unable to effectively repair DNA damage through the homologous recombination repair pathway. This deficiency is often linked... Read more

Image: Illumina’s acquisition of SomaLogic aims to strengthen its presence in the proteomics market (Photo courtesy of Illumina)

Illumina Acquires SomaLogic to Accelerate Proteomics Business

Illumina, Inc. (San Diego, CA, USA) has entered into a definitive agreement to acquire SomaLogic (Boulder, CO, USA), a leader in data-driven proteomics technology, and other specified assets for USD 350... Read more

Image: The new partnership aims to develop oncology assays for use on the QIAcuityDx platform (Photo courtesy of QIAGEN)

Qiagen and Gencurix Partner on Development of QIAcuity Digital PCR IVD Assay

QIAGEN (Venlo, Netherlands) and GENCURIX (Seoul, South Korea) have entered into a new partnership to develop oncology assays for use on the QIAcuityDx platform, a high-performance digital PCR system designed... Read more

QIAGEN and Incyte Enter into Precision Medicine Collaboration

Myeloproliferative neoplasms (MPNs) are a closely related group of rare blood cancers representing about 40% of hematological malignancies, characterized by chronic accumulation of different mature blood... Read more